Biotech investors wary of Warren tax proposals
Why biotech investors think Warren’s plan could disincentivize long-term investing
Biotech investors are concerned that Sen. Elizabeth Warren’s plans for funding Medicare for All could disincentivize the long-term investments that are the industry’s lifeblood. They are especially worried about unintended consequences of a proposal to tax capital gains annually, rather than when assets are sold.
Warren (D-Mass.) wants to